News

November 1, 2011 – Boston Scientific released the schedule of its major events and product-related clinical research for the Cardiovascular Research Foundation's (CRF) 23rd annual Transcatheter...

In a closely watched move viewed as a big step toward a paradigm shift in how heart valves are repaired in the United States, a U.S. Food and Drug Administration (FDA) advisory panel voted late...

October 7, 2011 – ValveXchange Inc., has performed successful first-in-man (FIM) surgeries demonstrating the practicality and advantages of its novel Vitality two-part heart valve system. Two...

October 3, 2011 — JenaValve Technology GmbH, a German medical device company specializing in the development of transcatheter heart valve implantation (TAVI) systems, announced it has received CE...

October 3, 2011 – Cardiac Dimensions Inc. announced it received European CE mark approval for a newly enhanced version of its Carillon Mitral Contour System, a therapy for treating heart failure...

September 15, 2011 – The Cardiovascular Research Foundation (CRF) has announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular...

September 12, 2011 — Cardiovascular market research firm Zacks Equity Research released a new report discussing high growth areas in medical devices, including Medtronic Inc., Boston Scientific...

August 30, 2011 – Results from a study presented at the European Society of Cardiology (ESC) Congress 2011 show that transcatheter aortic-valve implantation (TAVI) in low-risk patients met...

Aortic valve stenosis (intraoperatively)

August 30, 2011 – Single center data of the German Heart Centre in Munich demonstrate a sustained improvement of hemodynamic values up to three years after CoreValve implantation. There are no...

August 29, 2011 — An observational study demonstrates the percutaneous catheter-based MitraClip treatment improves symptoms and promotes reverse left ventricular (LV) remodeling in patients with...

August 19, 2011 - Neovasc Inc. accomplished $4.7 million in financing to complete the COSIRA clinical trial for the Neovasc Reducer to treat refractory angina. The company will also advance the...

August 8, 2011 – Edwards Lifesciences announced the global launch of the Carpentier-Edwards Physio Tricuspid Annuloplasty Ring for the treatment of tricuspid valve insufficiency. The company...

If approved by the U.S. Food and Drug Administration (FDA) later this summer, transcatheter valve therapy (TVT) – an innovative procedure that uses minimally invasive catheter-based technology to...
June 21, 2011 – The Heart Hospital of Austin, a physician-led hospital specializing in the diagnosis and treatment of cardiovascular disease in Austin, Texas, recently adopted the Philips iE33...
June 21, 2011 – The St. Francis Heart Center in Indianapolis, Ind., announced that it has performed the first post-U.S. Food and Drug Administration (FDA) approval surgery in the United States using...
June 14, 2011 – The first successful Chinese implants of the Edwards SAPIEN XT valve were performed in May.
June 10, 2011 - A U.S. Food and Drug Administration (FDA) advisory panel is scheduled to review Edwards Lifesciences’ premarket approval (PMA) application for the Sapien transcatheter heart valve on...
May 23, 2011 - A presentation about transcatheter aortic valve implantation (TAVI) at EuroPCR 2011 confirmed positive outcomes in patients receiving the CoreValve System from Medtronic Inc., across...
May 20, 2011 - Edwards Lifesciences Corporation announced that clinicians continued to achieve successful one-year outcomes in high-risk or inoperable patients undergoing transcatheter aortic valve...
May 19, 2011 – New clinical data presented today at EuroPCR 2011 demonstrate immediate and long-term health-related quality-of-life (HRQoL) benefits for patients receiving the Medtronic CoreValve...